We have located links that may give you full text access.
Case Reports
Journal Article
Terlipressin as rescue therapy in catecholamine-resistant hypotension in solid organ donors: a case report.
Transplantation Proceedings 2010 January
OBJECTIVE: The objective of this study was to report the effects of Terlipressin treatment in 2 potential organ donors with intractable, catecholamine-resistant hypotension.
DESIGN AND SETTING: This study was based on case reports in the intensive care unit of a general hospital.
PATIENTS: Patients included 2 adult patients with cerebral death and catecholamine-resistant hypotension.
INTERVENTIONS: A low dose of Terlipressin (3.5 microg/kg) by intravenous bolus was added to the standard treatment.
MEASUREMENT AND RESULTS: In both cases, Terlipressin induced a rapid improvement in arterial pressure with a consequent increase in urine output and the appearance of diabetes insipidus. In 1 patient it allowed for the withdrawal of norepinephrine infusion. No related adverse effects were detected in either patient. Organ removal was not possible in the second case due to lack of family consent.
CONCLUSIONS: Terlipressin might be considered as a rescue therapy for potential organ donors with intractable, catecholamine-resistant hypotension. In spite of the positive results obtained here and by other authors in the treatment of septic shock, its judicious use is recommended, and an optimal administration schedule must still be elucidated.
DESIGN AND SETTING: This study was based on case reports in the intensive care unit of a general hospital.
PATIENTS: Patients included 2 adult patients with cerebral death and catecholamine-resistant hypotension.
INTERVENTIONS: A low dose of Terlipressin (3.5 microg/kg) by intravenous bolus was added to the standard treatment.
MEASUREMENT AND RESULTS: In both cases, Terlipressin induced a rapid improvement in arterial pressure with a consequent increase in urine output and the appearance of diabetes insipidus. In 1 patient it allowed for the withdrawal of norepinephrine infusion. No related adverse effects were detected in either patient. Organ removal was not possible in the second case due to lack of family consent.
CONCLUSIONS: Terlipressin might be considered as a rescue therapy for potential organ donors with intractable, catecholamine-resistant hypotension. In spite of the positive results obtained here and by other authors in the treatment of septic shock, its judicious use is recommended, and an optimal administration schedule must still be elucidated.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app